Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT05083377 Completed - Clinical trials for Schizophrenia and Related Disorders

Clozapine Use Pattern in the Province of Seville

Start date: September 8, 2020
Phase:
Study type: Observational

CLOZAPINE USE PATTERN IN THE PROVINCE OF SEVILLE

NCT ID: NCT05083130 Completed - COVID-19 Clinical Trials

Awake Prone Positioning in Moderate to Severe COVID-19

Start date: March 8, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is comparing vital signs between standard care and prone position groups. Standard care will consist of routine clinical care, including any advice to lie in prone position as routinely recommended by participating sites. For those randomized to prone position, a special intervention team will visit patients' rooms aiming for patients to maintain the prone position for at least 8 hours a day.

NCT ID: NCT05082779 Completed - Clinical trials for Primary Sclerosing Cholangitis (PSC)

Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159

Start date: October 26, 2021
Phase: Phase 1
Study type: Interventional

The whole study includes 2 parts. Both the SAD study and MAD study are randomized, double-blinded, and placebo-controlled studies, conducted in healthy subjects, to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics profiles of CS0159. The SAD part also involves a pilot food effect (FE) study, designed to assess the food effect on single-dose PK profile in healthy subjects.

NCT ID: NCT05082415 Completed - Clinical trials for Age-related Macular Degeneration (AMD)

Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (IRIS Study)

Start date: June 3, 2020
Phase:
Study type: Observational

This study was a retrospective cohort study of patients to assess the early insights into real-world safety among wet AMD patients initiating brolucizumab. Evidence was generated to describe their patient characteristics and clinical outcomes. The study was conducted using the IRIS Registry.

NCT ID: NCT05082337 Completed - Clinical trials for Aortic Valve Stenosis

The SAVVY Guidewire in Transcatheter Aortic Valve Replacement Procedures

SAVVY
Start date: October 8, 2021
Phase: N/A
Study type: Interventional

TAVR patients exhibiting post-procedural residual AR had higher mortality and hospitalization rates due to heart failure, with the extent of this association increasing proportionally to the severity of the regurgitation. Optimizing transcatheter valve performance by intra-procedural hemodynamic evaluation of AR and residual transvalvular gradient remains of high clinical importance.

NCT ID: NCT05082051 Completed - Clinical trials for Exocrine Pancreatic Insufficiency

Oral CDX-7108 in Healthy Adults and EPI Subjects

Start date: October 11, 2021
Phase: Phase 1
Study type: Interventional

Phase 1a/1b single and multiple ascending dose study of oral CDX-7108 in healthy adult subjects and a single dose proof-of-concept study of oral CDX-7108 in subjects with exocrine pancreatic insufficiency. No clinical studies have yet been performed with CDX-7108 and its effects in humans are unknown. This is the first-in-human (FIH) study of CDX-7108, which aims to assess the safety, tolerability, pharmacokinetics (PK) of escalating single and multiple oral doses of CDX-7108 in healthy adult subjects and to evaluate the pharmacodynamics of a single dose of oral CDX-7108 in a proof-of-concept (POC) study in subjects with exocrine pancreatic insufficiency (EPI).

NCT ID: NCT05081661 Completed - Clinical trials for Anterior Cruciate Ligament Rupture

Effects of Corporal Visualisation Program of the Static and Dynamic Balance After an Operation of the LCA

Start date: March 8, 2022
Phase: N/A
Study type: Interventional

The aim of this pilot study is to assess the feasibility of a RCT whose topic would be the effect of a motor imagery program on the postural control in persons who have undergone ACL plasty.

NCT ID: NCT05080270 Completed - Multiple Sclerosis Clinical Trials

Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis

MSFibroblast
Start date: September 21, 2020
Phase: Early Phase 1
Study type: Interventional

Fibroblasts have demonstrated potent immune modulatory and therapeutic activity in the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis, as well as in other models of autoimmune and inflammatory diseases. This study will assess primary safety and secondary efficacy endpoints of intravenous administration of 100 million tolerogenic fibroblasts to 5 patients with relapsing remitting MS resistant to interferon. While the safety of fibroblasts administered clinically is established, it is unknown whether these cells are effective in the treatment of multiple sclerosis (MS). Our hypothesis is that the tolerogenic fibroblasts will be well-tolerated and meet our primary objective. In addition, The investigators are optimistic that they will see signs of efficacy based on the following: Neurological assessment of the MS functional composite assessment which comprises of EDSS, the expanded EDSS (Rating Neurologic Impairment in Multiple Sclerosis, the Scripps neurological rating scale (NRS), paced auditory serial addition test (PASAT), the nine-hole peg test, and 25-foot walking time, short-form 36 (SF-36) quality of life questionnaire and gadolinium-enhanced MRI scans of the brain and cervical spinal cord.

NCT ID: NCT05079009 Completed - Clinical trials for Acute Respiratory Distress Syndrome

Effects of Blood Pulsatility on Von Willebrand Factor During ECCO2R

FLOW-ECCO2R
Start date: January 28, 2022
Phase: N/A
Study type: Interventional

The primary objective of the study is to demonstrate that the ECCO2R pulsatile configuration prevents the Willebrand factor high molecular weight multimers decrease observed under continuous blood flow configurations. The secondary objectives are to quantify the CO2 extracorporeal removal in the pulsatile configuration, to describe complications (hemorrhagic, thrombotic and hemolytic), to describe patients' gas exchanges under ECCO2R, to describe the clinical course of the patients under ECCO2R as well as during the whole stay in the Intensive Care Unit (ICU).

NCT ID: NCT05078372 Completed - Clinical trials for Anterior Cruciate Ligament Injuries

Ropivacaine and Midazolam by Intraarticular vs Epidural Administration in Arthroscopic ACL

Start date: January 31, 2019
Phase: Phase 2
Study type: Interventional

Compare of the effectiveness of the use of ropivacaine and midazolam by intraarticular vs epidural administration on post-operative analgesia after isolated arthroscopic anterior cruciate ligament (ACL) reconstruction with hamstring autograft.